144 related articles for article (PubMed ID: 38325133)
1. Protective effects of exercise on cardiotoxicity induced by breast cancer treatments: A systematic review and meta-analysis.
Fernández-Casas A; Leirós-Rodríguez R; Hernandez-Lucas P; González-Represas A
Maturitas; 2024 May; 183():107932. PubMed ID: 38325133
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol.
Díaz-Balboa E; González-Salvado V; Rodríguez-Romero B; Martínez-Monzonís A; Pedreira-Pérez M; Palacios-Ozores P; López-López R; Peña-Gil C; González-Juanatey JR
BMC Cardiovasc Disord; 2021 Apr; 21(1):165. PubMed ID: 33827450
[TBL] [Abstract][Full Text] [Related]
3. Effects of physical exercise on outcomes of cardiac (dys)function in women with breast cancer undergoing anthracycline or trastuzumab treatment: study protocol for a systematic review.
Antunes P; Esteves D; Nunes C; Amarelo A; Fonseca-Moutinho J; Afreixo V; Costa H; Alves A; Joaquim A
Syst Rev; 2019 Oct; 8(1):239. PubMed ID: 31651372
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: a study protocol for a randomized controlled trial.
Antunes P; Esteves D; Nunes C; Sampaio F; Ascensão A; Vilela E; Teixeira M; Amarelo AL; Joaquim A
Trials; 2019 Jul; 20(1):433. PubMed ID: 31307527
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of Aerobic Exercise Training to Mitigate Cardiotoxicity of Breast Cancer Therapy: A Systematic Review and Meta-Analysis.
Tsai YL; Chuang YC; Chen CP; Lee YC; Cheng YY; Ou-Yang LJ
Clin Breast Cancer; 2023 Aug; 23(6):576-590. PubMed ID: 37286435
[TBL] [Abstract][Full Text] [Related]
7. Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study.
Foulkes SJ; Howden EJ; Haykowsky MJ; Antill Y; Salim A; Nightingale SS; Loi S; Claus P; Janssens K; Mitchell AM; Wright L; Costello BT; Lindqvist A; Burnham L; Wallace I; Daly RM; Fraser SF; La Gerche A
Circulation; 2023 Feb; 147(7):532-545. PubMed ID: 36342348
[TBL] [Abstract][Full Text] [Related]
8. A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study.
Jacquinot Q; Meneveau N; Chatot M; Bonnetain F; Degano B; Bouhaddi M; Dumoulin G; Vernerey D; Pivot X; Mougin F
BMC Cancer; 2017 Jun; 17(1):425. PubMed ID: 28629338
[TBL] [Abstract][Full Text] [Related]
9. Global Longitudinal Strain for the Early Detection of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis.
Cocco LD; Chiaparini AF; Saffi MAL; Leiria TLL
Clin Oncol (R Coll Radiol); 2022 Aug; 34(8):514-525. PubMed ID: 35637075
[TBL] [Abstract][Full Text] [Related]
10. Prevention of anthracycline-induced cardiotoxicity: a systematic review and network meta-analysis.
Alizadehasl A; Ghadimi N; Kaveh S; Maleki M; Ghavamzadeh A; Noohi F; Hosseinifard H
Int J Clin Pharm; 2021 Feb; 43(1):25-34. PubMed ID: 32910372
[TBL] [Abstract][Full Text] [Related]
11. The role of exercise in the prevention of cancer therapy-related cardiac dysfunction in breast cancer patients undergoing chemotherapy: systematic review.
Murray J; Bennett H; Bezak E; Perry R
Eur J Prev Cardiol; 2022 Mar; 29(3):463-472. PubMed ID: 33693524
[TBL] [Abstract][Full Text] [Related]
12. Attenuating Treatment-Related Cardiotoxicity in Women Recently Diagnosed With Breast Cancer via a Tailored Therapeutic Exercise Program: Protocol of the ATOPE Trial.
Postigo-Martin P; Peñafiel-Burkhardt R; Gallart-Aragón T; Alcaide-Lucena M; Artacho-Cordón F; Galiano-Castillo N; Fernández-Lao C; Martín-Martín L; Lozano-Lozano M; Ruíz-Vozmediano J; Moreno-Gutiérrez S; Illescas-Montes R; Arroyo-Morales M; Cantarero-Villanueva I
Phys Ther; 2021 Mar; 101(3):. PubMed ID: 33528004
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications.
Bikiewicz A; Banach M; von Haehling S; Maciejewski M; Bielecka-Dabrowa A
ESC Heart Fail; 2021 Aug; 8(4):2397-2418. PubMed ID: 33955207
[TBL] [Abstract][Full Text] [Related]
14. Exercise for women receiving adjuvant therapy for breast cancer.
Furmaniak AC; Menig M; Markes MH
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD005001. PubMed ID: 27650122
[TBL] [Abstract][Full Text] [Related]
15. Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients.
Howden EJ; Bigaran A; Beaudry R; Fraser S; Selig S; Foulkes S; Antill Y; Nightingale S; Loi S; Haykowsky MJ; La Gerche A
Eur J Prev Cardiol; 2019 Feb; 26(3):305-315. PubMed ID: 30376366
[TBL] [Abstract][Full Text] [Related]
16. Effect of Rosuvastatin in Preventing Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer: A Randomized, Single-Blind, Placebo-Controlled Trial.
Nabati M; Janbabai G; Esmailian J; Yazdani J
J Cardiovasc Pharmacol Ther; 2019 May; 24(3):233-241. PubMed ID: 30599756
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological interventions for preventing anthracycline-induced clinical and subclinical cardiotoxicity: A network meta-analysis of metastatic breast cancer.
Ghasemi K; Vaseghi G; Mansourian M
J Oncol Pharm Pract; 2021 Mar; 27(2):414-427. PubMed ID: 33081570
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic predictors of symptomatic cardiotoxicity among patients undergoing chemotherapy: A systematic review and meta-analysis.
Siddiqui MU; Yaacoub Y; Hanson HA; Junarta J; Pasha AK; Shah M
Medicine (Baltimore); 2022 Jul; 101(28):e29562. PubMed ID: 35839035
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer: A Randomized Clinical Trial.
Boekhout AH; Gietema JA; Milojkovic Kerklaan B; van Werkhoven ED; Altena R; Honkoop A; Los M; Smit WM; Nieboer P; Smorenburg CH; Mandigers CM; van der Wouw AJ; Kessels L; van der Velden AW; Ottevanger PB; Smilde T; de Boer J; van Veldhuisen DJ; Kema IP; de Vries EG; Schellens JH
JAMA Oncol; 2016 Aug; 2(8):1030-7. PubMed ID: 27348762
[TBL] [Abstract][Full Text] [Related]
20. Exercise interventions on health-related quality of life for people with cancer during active treatment.
Mishra SI; Scherer RW; Snyder C; Geigle PM; Berlanstein DR; Topaloglu O
Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD008465. PubMed ID: 22895974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
